Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 978,228 shares at $160.96 ($158.7M) on 2021-01-20, disclosed to the SEC on 2021-01-21.
Open-market sale of $158.7M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.22 | 10,741 | $1.7M | 1.1% |
| 2 | $158.22 | 10,741 | $1.7M | 1.1% |
| 3 | $159.16 | 12,506 | $2.0M | 1.3% |
| 4 | $159.16 | 12,506 | $2.0M | 1.3% |
| 5 | $160.02 | 49,841 | $8.0M | 5.0% |
| 6 | $160.02 | 49,841 |
| $8.0M |
| 5.0% |
| 7 | $161.07 | 21,344 | $3.4M | 2.2% |
| 8 | $161.07 | 21,344 | $3.4M | 2.2% |
| 9 | $161.95 | 9,285 | $1.5M | 0.9% |
| 10 | $161.95 | 9,285 | $1.5M | 0.9% |
| 11 | $160.95 | 6,557 | $1.1M | 0.7% |
| 12 | $160.95 | 6,557 | $1.1M | 0.7% |
| 13 | $160.96 | 26,243 | $4.2M | 2.7% |
| 14 | $160.96 | 26,243 | $4.2M | 2.7% |
| 15 | $161.89 | 34,584 | $5.6M | 3.5% |
| 16 | $161.89 | 8,755 | $1.4M | 0.9% |
| 17 | $161.89 | 8,755 | $1.4M | 0.9% |
| 18 | $161.89 | 34,584 | $5.6M | 3.5% |
| 19 | $162.90 | 21,882 | $3.6M | 2.2% |
| 20 | $162.90 | 21,882 | $3.6M | 2.2% |
| 21 | $162.95 | 8,174 | $1.3M | 0.8% |
| 22 | $162.95 | 8,174 | $1.3M | 0.8% |
| 23 | $163.86 | 8,169 | $1.3M | 0.8% |
| 24 | $163.86 | 8,169 | $1.3M | 0.8% |
| 25 | $163.91 | 29,995 | $4.9M | 3.1% |
| 26 | $163.91 | 29,995 | $4.9M | 3.1% |
| 27 | $164.56 | 24,623 | $4.1M | 2.6% |
| 28 | $164.56 | 24,623 | $4.1M | 2.6% |
| 29 | $164.58 | 4,380 | $721K | 0.5% |
| 30 | $164.58 | 4,380 | $721K | 0.5% |
| 31 | $165.82 | 11,104 | $1.8M | 1.2% |
| 32 | $165.82 | 11,104 | $1.8M | 1.2% |
| 33 | $165.82 | 2,819 | $467K | 0.3% |
| 34 | $165.82 | 2,819 | $467K | 0.3% |
| 35 | $166.83 | 5,149 | $859K | 0.5% |
| 36 | $166.83 | 5,149 | $859K | 0.5% |
| 37 | $166.87 | 1,908 | $318K | 0.2% |
| 38 | $166.87 | 1,908 | $318K | 0.2% |
| 39 | $167.77 | 14,083 | $2.4M | 1.5% |
| 40 | $167.77 | 14,083 | $2.4M | 1.5% |
| 41 | $167.81 | 3,766 | $632K | 0.4% |
| 42 | $167.81 | 3,766 | $632K | 0.4% |
| 43 | $160.29 | 3,806 | $610K | 0.4% |
| 44 | $160.29 | 3,806 | $610K | 0.4% |
| 45 | $161.17 | 33,422 | $5.4M | 3.4% |
| 46 | $161.17 | 33,422 | $5.4M | 3.4% |
| 47 | $162.08 | 118,726 | $19.2M | 12.1% |
| 48 | $162.08 | 118,726 | $19.2M | 12.1% |
| 49 | $162.71 | 6,530 | $1.1M | 0.7% |
| 50 | $162.71 | 6,530 | $1.1M | 0.7% |
| 51 | $164.01 | 10,722 | $1.8M | 1.1% |
| 52 | $164.01 | 10,722 | $1.8M | 1.1% |
| Total | $162.27 avg | 978,228 | $158.7M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |